MEM-288 (solid tumors)

What is the Purpose of this Study?

If you choose to join this study, you will:
- Take the study drug (MEM-288)
- Provide tumor tissue
- Have physical exams, blood draws, and give urine samples
- Have imaging scans (CT and MRI)
- Have heart tests (ECG)
What is the Condition Being Studied?
Advanced Solid Tumors

Who Can Participate in this Study?

Adults diagnosed with the following cancers that have spread:

- Non-small cell lung cancer (NSCLC)

- Cutaneous squamous-cell carcinoma (cSCC)

- Merkel cell carcinoma

- Melanoma

- Triple negative breast cancer (TNBC)

- Pancreatic cancer

- Head and neck cancer

Age Group
Adults
Participating Institutions

What is Involved?

We are doing this study to find out if an experimental drug called MEM-288 (the study drug) is a safe and effective treatment for your cancer.

Study Details

Full Title
Phase I Study of MEM-288 Oncolytic Virus in Solid Tumors including Non-Small Cell Lung Cancer (NSCLC)
Principal Investigator

Protocol Number
IRB:
PRO00109517

NCT:
NCT05076760
ClinicalTrials.gov
View on ClinicalTrials.gov